Lucid Diagnostics LUCD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -959.6%+95.2pp | -1,054.8%+36.4pp | -1,091.3%+8.3pp | -1,099.5%+44.7pp | -1,144.2%-84.5pp | |
| Net margin | -876.7%+356pp | -1,232.7%-21.4pp | -1,211.3%+56.1pp | -1,267.4%+214pp | -1,481.5%-434pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.1×-0.2× | 1.3×-0.6× | 1.9×+0.8× | 1.1×+0.4× | 0.8×-0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×— | —— | —— | —— | —— | |
| Valuation | ||||||
| Market capitalization | $204.13M+58.5% | $142.9M+38.9% | $102.91M-20.1% | $128.75M-4.8% | $135.22M+178% | |
| Price / sales | 39.8×+10.2× | 30.4×+7.0× | 23.4×-6.1× | 29.5×-2.9× | 32.4×+21.2× | |
| Price / book | 51×+34.7× | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lucid Diagnostics's profit margins?
- Lucid Diagnostics (LUCD) runs a -66.8% gross margin and a -959.6% operating margin, with a -876.7% net margin.
- Where do Lucid Diagnostics's ratios come from?
- Every ratio is computed from Lucid Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
